SwePub
Sök i LIBRIS databas

  Utökad sökning

WFRF:(Mattsson Johanna)
 

Sökning: WFRF:(Mattsson Johanna) > Highly elevated sys...

Highly elevated systemic inflammation is a strong independent predictor of early mortality in advanced non-small cell lung cancer

Isaksson, Johan (författare)
Uppsala universitet,Science for Life Laboratory, SciLifeLab,Centrum för klinisk forskning, Gävleborg,Cancerprecisionsmedicin,Department of Respiratory Medicine, Gävle Hospital, Gävle, Sweden
Wennström, Leo (författare)
Uppsala universitet,Centrum för klinisk forskning, Gävleborg,Department of Respiratory Medicine, Gävle Hospital, Gävle, Sweden
Brandén, Eva (författare)
Uppsala universitet,Centrum för klinisk forskning, Gävleborg,Department of Respiratory Medicine, Gävle Hospital, Gävle, Sweden
visa fler...
Koyi, Hirsh (författare)
Uppsala universitet,Centrum för klinisk forskning, Gävleborg,Department of Respiratory Medicine, Gävle Hospital, Gävle, Sweden;Department of Oncology–Pathology, Karolinska Biomics Center, Karolinska Institutet, Stockholm, Sweden
Berglund, Anders (författare)
EpiStat, Uppsala, Sweden
Micke, Patrick (författare)
Uppsala universitet,Science for Life Laboratory, SciLifeLab,Cancerimmunterapi
Mattsson, Johanna Sofia Margareta, 1985- (författare)
Uppsala universitet,Science for Life Laboratory, SciLifeLab,Cancerimmunterapi
Willén, Linda, 1979- (författare)
Uppsala universitet,Centrum för klinisk forskning, Gävleborg,Department of Radiation Sciences and Oncology, Umeå University Hospital, Umeå, Sweden;Department of Oncology, Gävle Hospital, Gävle, Sweden
Botling, Johan (författare)
Uppsala universitet,Science for Life Laboratory, SciLifeLab,Cancerimmunterapi
visa färre...
 (creator_code:org_t)
Elsevier, 2022
2022
Engelska.
Ingår i: Cancer Treatment and Research Communications. - : Elsevier. - 2468-2942. ; 31
  • Tidskriftsartikel (refereegranskat)
Abstract Ämnesord
Stäng  
  • BackgroundAmple evidence support inflammation as a marker of outcome in non-small cell lung cancer (NSCLC). Here we explore the outcome for a subgroup of patients with advanced disease and substantially elevated systemic inflammatory activity.MethodsThe source cohort included consecutive patients diagnosed with NSCLC between January 2016 – May 2017 (n = 155). Patients with active infection were excluded. Blood parameters were examined individually, and cut-offs (ESR > 60 mm, CRP > 20 mg/L, WBC > 10 × 109, PLT > 400 × 109) were set to define the group of hyperinflamed patients. A score was developed by assigning one point for each parameter above cut-off (0–4 points).ResultsHigh systemic inflammation was associated with advanced stage and was seldom present in limited NSCLC. However, the one year survival of patients in stage IIIB-IV (n = 93) with an inflammation score of ≥2 was 0% compared to 33% and 50% among patients with a score of 1 and 0 respectively. The effect of a high inflammation score on overall survival remained significant in multi-variate analysis adjusted for confounding factors. The independent hazard ratio of an inflammation score ≥ 2 in multi-variate analysis (HR 3.43, CI 1.76–6.71) was comparable to a change in ECOG PS from 0 to 2 (HR 2.42, CI 1.13–5.18).ConclusionOur results show that high level systemic inflammation is a strong independent predictor of poor survival in advanced stage NSCLC. This observation may indicate a need to use hyperinflammation as an additional clinical parameter for stratification of patients in clinical studies and warrants further research on underlying mechanisms linked to tumor progression.

Ämnesord

MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin -- Cancer och onkologi (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine -- Cancer and Oncology (hsv//eng)

Nyckelord

Lung cancer
Inflammation
NSCLC
Survival
C-reactive protein

Publikations- och innehållstyp

ref (ämneskategori)
art (ämneskategori)

Hitta via bibliotek

Till lärosätets databas

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy